Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.

Andrea IannoneMarinella RuospoGermaine WongMichele Barone Mariabeatrice PrincipiAlfredo Di LeoGiovanni F M Strippoli

Published in: Canadian journal of gastroenterology & hepatology (2018)

Mesalazine may reduce recurrences in symptomatic uncomplicated diverticular disease. There is uncertainty on the effect of mesalazine in achieving diverticular disease remission. Mesalazine may not prevent acute diverticulitis in symptomatic uncomplicated diverticular disease.

Keyphrases

liver failure
intensive care unit
rheumatoid arthritis
systemic lupus erythematosus
respiratory failure
disease activity
acute respiratory distress syndrome